Public Company
Sawaya Segalas is widely recognized for providing independent and unbiased advice to the management and Board of Directors of public companies in the consumer industry. Our teams are made up of senior bankers, many with more than 10 years experience. In addition, we believe that our proven ability to work with executives at all levels of the organization and on both "sides of the table" is a key factor in achieving successful outcomes.
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Corporate Divestiture | General Advisory |
Public Company
Brand: Bonine
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: WellSpring Pharmaceutical Corp., Sentinel Capital Partners
Transaction Value: Undisclosed
Closing Date: September 3, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Public Company
Brands: Monistat, EPT, and Nix among others
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Insight Pharmaceuticals, LLC., Swander Pace Capital
Transaction Value: $750.0 million
Closing Date: September 3, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News      arrow  View Investor Call
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Brand: Hydralyte
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Hydration Pharmaceuticals Trust of Victoria, Australia
Transaction Value: $50.0 million (AUD)
Closing Date: May 1, 2014
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | Public Company
Brand: Care Pharmaceuticals
Owner/Parent: Prestige Brands Holdings, Inc.
Counterparty: Care Pharmaceuticals
Transaction Value: Undisclosed
Closing Date: July 1, 2013
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: Debrox®, Gly-Oxide®
Transaction Value: $45.0 million
Closing Date: April 2, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Cross Border |
Public Company
Counterparty: GlaxoSmithKline plc
Brands: BC®, Goody's®, Ecotrin®, Beano®, Gaviscon®, Phazyme®, Tagamet®, Fiber Choice®, GI Brands and Sominex® among others
Transaction Value: $615.0 million
Closing Date: January 31, 2012
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News      arrow  View Investor Presentation
 
Pennzoil Quaker State Company  
Pennzoil-Quaker State Company/Royal Dutch Shell plc
Household Products & DIY | Corporate Divestiture | Public Company
Brands: Rain X, Gumout, Black Magic, Fix-A-Flat, Blue Coral, Slick 50
Owner/Parent: Royal Dutch Shell
Counterparty: Illinois Tool Works Inc.
Transaction Value: Undisclosed
Closing Date: February 28, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Matrixx Initiatives, Inc.  
Matrixx Initiatives, Inc.
Personal Care, OTC & Cosmetics | Sell-Side | Public Company
Brand: Zicam
Counterparty: H.I.G. Capital
Transaction Value: $75.2 million
Closing Date: February 18, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Prestige  
Prestige Brands Holdings, Inc.
Personal Care, OTC & Cosmetics | Buy-Side | General Advisory | Public Company
Counterparty: McNeil-PPC, Inc.
Brand: Dramamine
Transaction Value: $76.0 million
Closing Date: January 6, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
GlaxoSmithKline  
GlaxoSmithKline
Personal Care, OTC & Cosmetics | Corporate Divestiture | Cross-Border | Public Company
Brands: Contac, Vivarin
Counterparty: Meda AB
Transaction Value: $27.0 million
Closing Date: January 3, 2011
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
GlaxoSmithKline  
GlaxoSmithKline
Personal Care, OTC & Cosmetics | Corporate Divestiture | Cross-Border | Public Company
Brands: Feosol, Geritol, Palafer
Counterparty: Meda AB
Transaction Value: $34.0 million
Closing Date: December 13, 2010
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News
 
Church & Dwight  
Church & Dwight Co., Inc.
Household Products & DIY | Corporate Divestiture | Public Company
Brand: Brillo®
Counterparty: Armaly Brands
Transaction Value: Undisclosed
Closing Date: March 12, 2010
Role: Exclusive Financial Advisor
View Related News  arrow  View Related News